Adaptive Biotechnologies Insider Sells After Doubling Rally
When a company’s stock doubles and an insider sells a large block, investors should ask: what’s really going on? This...
An easy reference to world market indices names, with notes on regional coverage and how to recognize key benchmarks in discussions.
28,329 articlesWhen a company’s stock doubles and an insider sells a large block, investors should ask: what’s really going on? This...
Analysts are shifting views on crypto firms, labeling them as core market infrastructure rather than mere tokens. The...
Investors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
President Trump pushes the DOJ to investigate alleged price gouging by major oil firms, citing pump prices while dono...
Lovesac’s Q1 2027 narrative offers clues about demand, margins, and strategy for the year ahead. This article breaks ...
Investors are focusing on the links between battlefield tech and defense earnings as analysts highlight the firearms ...
Investors are asking, Has Intel's stock peaked? This in-depth guide breaks down the catalysts, risks, and valuation s...
Lockheed Martin has surged about 26% in 2026. Before you chase the rally, learn how to assess whether the stock still...
GE Vernova reports $18.3 billion in Q1 2026 orders and a $150 billion backlog, underscoring a durable AI-driven capex...
OpenAI moves to turn ChatGPT into a multi‑tool platform ahead of a likely IPO this year. The plan centers on a broad ...
As SpaceX IPO chatter grows, investors seek breadth over a single-name bet. A diversified space ETF offers exposure t...
SpaceX's public debut sparked wide debate. This guide explains what a $2,000 investment could look like under differe...